The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 30, 2017
Filed:
Oct. 07, 2013
Applicant:
Angion Biomedica Corporation, Uniondale, NY (US);
Inventors:
David E. Zembower, La Grange, IL (US);
David A. Eiznhamer, Bloomingdale, IL (US);
Assignee:
Angion Biomedica Corporation, Uniondale, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/12 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 405/06 (2006.01); C07D 405/14 (2006.01); C07D 409/06 (2006.01); C07D 409/14 (2006.01); A61K 31/4155 (2006.01);
U.S. Cl.
CPC ...
C07D 231/12 (2013.01); A61K 31/4155 (2013.01); C07D 401/06 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/14 (2013.01); C07D 409/06 (2013.01); C07D 409/14 (2013.01);
Abstract
The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein R, Rand B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role.